Ibutamoren, also known as MK-677, is a growth hormone secretagogue developed in the 1990s by Merck. It mimics ghrelin and stimulates the release of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Unlike traditional GH therapies, it is taken orally and has a long half-life, allowing once-daily dosing. Initially studied for conditions like muscle wasting and osteoporosis, it remains unapproved for medical use but is popular in bodybuilding for its muscle-building and fat-loss effects. Potential side effects include increased appetite, water retention, and insulin resistance .
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about MK 677 by Dragon Pharma, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.